10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $379,995 | -26.1% | 9,212 | 0.0% | 0.07% | -12.9% |
| Q2 2023 | $514,398 | +35.3% | 9,212 | +35.1% | 0.08% | +23.2% |
| Q1 2023 | $380,320 | +6.8% | 6,817 | -30.2% | 0.07% | +7.8% |
| Q4 2022 | $356,055 | +28.1% | 9,771 | 0.0% | 0.06% | +10.3% |
| Q3 2022 | $278,000 | -37.9% | 9,771 | -1.3% | 0.06% | -37.0% |
| Q2 2022 | $448,000 | -40.5% | 9,903 | 0.0% | 0.09% | -28.7% |
| Q1 2022 | $753,000 | -48.9% | 9,903 | 0.0% | 0.13% | -50.4% |
| Q4 2021 | $1,475,000 | +3.7% | 9,903 | +1.4% | 0.26% | +14.0% |
| Q3 2021 | $1,422,000 | -21.2% | 9,771 | +6.0% | 0.23% | -20.3% |
| Q2 2021 | $1,805,000 | +23.2% | 9,217 | -13.6% | 0.29% | +11.3% |
| Q1 2021 | $1,465,000 | +97.4% | 10,672 | +103.5% | 0.26% | +123.5% |
| Q4 2020 | $742,000 | +124.8% | 5,243 | +98.1% | 0.12% | +79.7% |
| Q3 2020 | $330,000 | – | 2,646 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |